REFERENCES
- Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993;361:315–325.
- Chang JS, Noh DY, Park IA. Overexpression of phospholipase C-gamma1 in rat 3Y1 fibroblast cells leads to malignant transformation. Cancer Res 1997;57:5465–5468.
- Chang JS, Iwashita S, Lee YH, Kim MJ, Ryu SH, Suh PG. Transformation of rat fibroblasts by phospholipase C-gamma1 overexpression is accompanied by tyrosine dephosphorylation of paxillin. FEBS Lett 1999;460:161–165.
- Lee SJ, Lee SD, Park JG, Kim CM, Ryu SH, Suh PG. Overexpression of phospholipase C-gamma 1 in colorectal carcinomas is associated with overexpression of factors that bind its promoter. J Biol Chem 1995;270:16378–16384.
- Noh DY, Lee YH, Kim SS. Elevated content of phospholipase C-gamma 1 in colorectal cancer tissues. Cancer 1994;73:36–41.
- Park JG, Lee YH, Kim SS. Overexpression of phospholipase C-gamma 1 in familial adenomatous polyposis. Cancer Res 1994;58:2240–2244.
- Arteaga CL, Johnson MD, Todderud G, Coffey RJ, Carpenter G, Page DL. Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A 1991;88:10435–10439.
- Song S, Finkel T. GAPDH and the search for alternative energy. Nat Cell Biol 2007;9:869–870.
- Vila MR, Nicolas A, Morote J, de I, Meseguer A. Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction. Cancer 2000;89:152–164.
- Rondinelli RH, Epner DE, Tricoli JV. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer. Prostate Cancer Prostatic Dis 1997;1:66–72.
- Revillion F, Pawlowski V, Hornez L, Peyrat JP. Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer. Eur J Cancer 2000;36:1038–1042.
- Bonafe N, Gilmore-Hebert M, Folk NL, Azodi M, Zhou Y, Chambers SK. Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3’ untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype. Cancer Res 2005;65:3762–3771.
- Hacker HJ, Bannasch P, Columbano A. Effect of lead nitrate on liver carbohydrate enzymes and glycogen content in the rat. Carcinogenesis 1990;11:2199–2204.
- Epner DE, Partin AW, Schalken JA, Isaacs JT, Coffey DS. Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma. Cancer Res 1993;53:1995–1997.
- Terpstra M, Gruetter R, High WB. Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. Cancer Res 1998;58:5083–5088.
- Inoue H, Tavoloni N, Hanafusa H. Suppression of v-Src transformation in primary rat embryo fibroblasts. Oncogene 1995;11: 231–238.
- Rong R, Ahn JY, Chen P, Suh PG, Ye K. Phospholipase activity of phospholipase C-gamma1 is required for nerve growth factor-regulated MAP kinase signaling cascade in PC12 cells. J Biol Chem 2003;278:52497–52503.
- Ji QS, Winnier GE, Niswender KD. Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development. Proc Natl Acad Sci U S A 1997;94:2999–3003.
- Miao J, Xiao Z, Kanamaluru D. Bile acid signaling pathways increase stability of small heterodimer partner (SHP) by inhibiting ubiquitin-proteasomal degradation. Genes Dev 2009;23:986–996.
- Ke N, Claassen G, Yu DH. Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 2004;64:8208–8212.
- Xu RH, Pelicano H, Zhou Y. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 2005;65:613–621.
- Smith MR, Liu YL, Matthews NT, Rhee SG, Sung WK, Kung HF. Phospholipase C-gamma 1 can induce DNA synthesis by a mechanism independent of its lipase activity. Proc Natl Acad Sci U S A 1994;91:6554–6558.
- Homma Y, Takenawa T, Emori Y, Sorimachi H, Suzuki K. Tissue- and cell type-specific expression of mRNAs for four types of inositol phospholipid-specific phospholipase C. Biochem Biophys Res Commun 1989;164:406–412.
- Marshall AJ, Niiro H, Yun TJ, Clark EA. Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase C gamma pathway. Immunol Rev 2000;176: 30–46.
- Friedman ZY. Recurrent advances in understaning the molecular mechanisms of tamoxifen action. Cancer Invest 1998;16:391–396.
- Bai XC, Deng F, Liu AL. Phospholipase C-gamma1 is required for cell survival in oxidative stress by protein kinase C. Biochem J 2002;363:395–401.
- Mangat R, Singal T, Dhalla NS, Tappia PS. Inhibition of phospholipase C-gamma 1 augments the decrease in cardiomyocyte viability by H2O2. Am J Physiol Heart Circ Physiol 2006;291:H854–H860.
- Kassis J, Moellinger J, Lo H, Greenberg NM, Kim HG, Wells A. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. Clin Cancer Res 1999;5:2251–2260.
- Shepard CR, Kassis J, Whaley DL, Kim HG, Wells A. PLC gamma contributes to metastasis of in situ-occurring mammary and prostate tumors. Oncogene 2007;26:3020–3026.
- Clapham DE. TRP channels as cellular sensors. Nature 2003;426: 517–524.
- Patterson RL, van Rossum DB, Ford DL. Phospholipase C-gamma is required for agonist-induced Ca2+ entry. Cell 2002;111: 529–541.
- Huang PS, Davis L, Huber H. An SH3 domain is required for the mitogenic activity of microinjected phospholipase C-gamma 1. FEBS Lett 1995;358:287–292.
- Yun S, Moller A, Chae SK. Siah proteins induce the epidermal growth factor-dependent degradation of phospholipase Cepsilon. J Biol Chem 2008;283:1034–1042.
- Desprez PY, Poujol D, Saez S. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, E.C. 1.2.1.12.) gene expression in two malignant human mammary epithelial cell lines: BT-20 and MCF-7. Regulation of gene expression by 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3). Cancer Lett 1992;64:219–224.
- Fuentes MV, Saez S, Trelis M, Galan-Puchades MT, Esteban JG. The helminth community of the wood mouse, Apodemus sylvaticus, in the Sierra Espuna, Murcia, Spain. J Helminthol 2004;78:219–223.
- Piechaczyk M, Blanchard JM, Marty L. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acids Res 1984;12:6951–6963.
- Cool BL, Sirover MA. Immunocytochemical localization of the base excision repair enzyme uracil DNA glycosylase in quiescent and proliferating normal human cells. Cancer Res 1989;49: 3029–3036.
- Meyer-Siegler K, Rahman-Mansur N, Wurzer JC, Sirover MA. Proliferative dependent regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in human cells. Carcinogenesis 1992;13:2127–2132.
- Mansur NR, Meyer-Siegler K, Wurzer JC, Sirover MA. Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in normal human cells. Nucleic Acids Res 1993;21:993–998.
- Netzker R, Hermfisse U, Wein KH, Brand K. Expression of glycolytic isozymes in rat thymocytes during cell cycle progression. Biochim Biophys Acta 1994;1224:371–376.
- Sen N, Hara MR, Kornberg MD. Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis. Nat Cell Biol 2008;10:866–873.
- Sergienko EA, Kharitonenkov AI, Bulargina TV, Muronetz VV, Nagradova NK. D-glyceraldehyde-3-phosphate dehydrogenase purified from rabbit muscle contains phosphotyrosine. FEBS Lett 1992;304:21–23.
- Caswell AH, Corbett AM. Interaction of glyceraldehyde-3-phosphate dehydrogenase with isolated microsomal subfractions of skeletal muscle. J Biol Chem 1985;260:6892– 6898.
- Vollberg TM, Siegler KM, Cool BL, Sirover MA. Isolation and characterization of the human uracil DNA glycosylase gene. Proc Natl Acad Sci U S A 1989;86:8693–8697.
- Ishitani R, Chuang DM. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. Proc Natl Acad Sci U S A 1996;3:9937–9941.